Skip to main content

Acute Myeloid Leukemia: FLT3/NPM1

  • Chapter
  • First Online:
Diagnostic Molecular Pathology in Practice
  • 2251 Accesses

Abstract

A 74-year-old male was found to have pancytopenia with low vitamin B12 levels on routine physical exam with his primary care physician. He complained of increasing fatigue over the last several months, which he attributed to his advancing age, but otherwise felt well. The patient denied any other symptoms. Pertinent family history revealed that his father died of acute leukemia at the age of 66 and his mother died at age 78 with heart complications and possible chronic lymphocytic leukemia. His primary care physician attempted to treat him with vitamin B12 in an effort to address the low levels, but there was no response. For additional assessment of his pancytopenia, the patient was referred to a hematologist who ordered laboratory studies to evaluate his peripheral blood and bone marrow. A complete blood count (CBC) showed megaloblastic anemia, a critically low white blood cell count, and thrombocytopenia. Upon review of the peripheral smear, the pathologist noted moderate anisopoikilocytosis of the red cells and rare circulating blasts. On aspirate smear, an increase in blasts was identified comprising approximately 30% of total nucleated cells. Erythroid precursors were markedly decreased. The core biopsy of the bone marrow correlated with these findings and showed decreased marrow cellularity of approximately 10%. A patchy interstitial increase in blasts was noted, comprising approximately 20% of total nucleated cells. Megakaryocytes were also decreased. Flow cytometric analysis on bone marrow revealed a distinct population of cells, comprising 20% of the total sample which expressed CD13, CD33 (low density), CD34, CD38, CD117, HLA-DR, and CD 45 (low density).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gregory T, Wald D, Chen Y et al (2009) Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics. J Hematol Oncol 2:23–33

    Article  PubMed  PubMed Central  Google Scholar 

  2. Schnittger S, Schoch C, Kern W et al (2005) Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype. Blood 106:3733–3739

    Article  PubMed  CAS  Google Scholar 

  3. Marcucci G, Mrozek K, Bloomfield C (2005) Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics. Curr Opin Hematol 12:68–75

    Article  PubMed  CAS  Google Scholar 

  4. Smith-Zagone M, Pulliam J, Farkas D (2006) Molecular pathology methods. In: Leonard D (ed) Molecular pathology in clinical practice. Springer, New York, pp 15–40

    Google Scholar 

  5. Chen W, Rassidakis G, Medeiros L (2006) Nucleophosmin gene mutations in acute myeloid leukemia. Arch Pathol Lab Med 130:1687–1692

    PubMed  CAS  Google Scholar 

  6. Rau R, Brown P (2009) Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity. Hematol Oncol 27:171–181

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Mrozek K, Heerema N, Bloomfield C (2004) Cytogenetics in acute leukemia. Blood Rev 18:115–136

    Article  PubMed  Google Scholar 

  8. Arber D, Brunning R, Le Beau M et al (2008) Acute myeloid leukaemia with recurrent genetic abnormalities. In: Swerdlow SH, Campo E, Harris N, Swerdlow SH, Campo E, Harris N et al (eds) WHO classification of tumors of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, pp 110–123

    Google Scholar 

  9. Bacher U, Schnittger S, Haferlach C et al (2009) Molecular diagnostics in acute leukemias. Clin Chem Lab Med 47:1333–1341

    Article  PubMed  CAS  Google Scholar 

  10. Leroy H, de Botton S, Grardel-Duflos N et al (2005) Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21). Leukemia 19:367–372

    Article  PubMed  CAS  Google Scholar 

  11. Krauter J, Gorlich K, Ottman O et al (2003) Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias. J Clin Oncol 21:4413–4422

    Article  PubMed  CAS  Google Scholar 

  12. Schnittger S, Weisser M, Schoch C et al (2003) New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcripts. Blood 102:2746–2755

    Article  PubMed  CAS  Google Scholar 

  13. Meshinchi S, Alonzo T, Stirewalt D et al (2006) Clinical implications of FLT3 mutations in pediatric AML. Blood 108:3654–3661

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  14. Pratz K, Sato T, Murphy K et al (2010) FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML. Blood 115:1425–1432

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  15. Small D (2006) FLT3 mutations: biology and treatment. Hematology 2006:178–184

    Article  Google Scholar 

  16. Bacher U, Haferlach C, Kern W et al (2008) Prognostic relevance of FLT3-TKD mutations in AML: the combination matters–an analysis of 3082 patients. Blood 111:2527–2537

    Article  PubMed  CAS  Google Scholar 

  17. Falini B, Sportoletti P, Martelli M (2009) Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives. Curr Opin Oncol 21:573–581

    Article  PubMed  Google Scholar 

  18. Gulley M, Shea T, Fedoriw Y (2010) Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia. J Mol Diagn 12:3–16

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ruan T. Ramjit .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ramjit, R.T., Hill, C.E. (2011). Acute Myeloid Leukemia: FLT3/NPM1 . In: Schrijver, I. (eds) Diagnostic Molecular Pathology in Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19677-5_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-19677-5_17

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-19676-8

  • Online ISBN: 978-3-642-19677-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics